Cytosorbents board of directors
WebApr 13, 2024 · We note that hedge funds don't have a meaningful investment in Cytosorbents. Looking at our data, we can see that the largest shareholder is Robert Shipley with 6.6% of shares outstanding. In... Web(ii) as the result of or in connection with any cash tender offer, exchange offer, sale of assets, merger, consolidation or other business combination of the Company with another corporation or entity the new Board of Directors is comprised of a majority of Directors chosen or elected by the shareholders of the new/combined entity who were not …
Cytosorbents board of directors
Did you know?
WebAug 15, 2024 · Registrant’s telephone number, including area code: (732) 329-8885 Not Applicable (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction … WebJun 1, 2024 · a majority of the members of the Board are replaced during any twelve-month period by directors whose appointment or election is not endorsed by a majority of the Board before the date of appointment or election; or (iv) the sale of all or substantially all of the Company’s assets.
WebFOR VALUE RECEIVED, the undersigned CytoSorbents Corporation (the “Company”), promises to pay in equity as set forth below on or before February 15, 2013, to _____ (“Creditor"), at New York, NY the principal sum of one million two hundred fifty thousand dollars ($1,250,000.00) (the “Principal”), together with interest accruing thereon at the … WebExhibit 99.1 . CytoSorbents Appoints Jiny Kim, MBA to its Board of Directors . MONMOUTH JUNCTION, N.J., April 5, 2024 — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces the appointment of Ms. Jiny Kim, …
Webdirectors, each of whom must be determined by the Board to satisfy the independence and experience requirements of the NASDAQ Stock Market (“NASDAQ”), provided that the Committee membership shall be subject to the exemptions afforded issuers under SEC and NASDAQ rules. Specifically, one director who does not meet the independence cr iteria of
WebCytoSorbents Corporation EMPLOYEE 7 Justia Legal Resources Find a Lawyer Bankruptcy Lawyers Business Lawyers Criminal Lawyers Employment Lawyers Estate Planning Lawyers Family Lawyers Personal Injury Lawyers More... Individuals Bankruptcy Criminal Divorce DUI Estate Planning Family Law Personal Injury More... Business …
WebBOARD OF DIRECTORS - Cytosorbents BOARD OF DIRECTORS Al W. Kraus Chairman of the Board Mr. Kraus joined the company in August 2003 as Chief Executive Officer and Director. Mr. Kraus stepped down as CEO at the end of 2008 and was … CytoSorbents operates through its wholly-owned subsidiary, CytoSorbents … Dr. Phillip Chan is the Chief Executive Officer of CytoSorbents Corporation … CytoSorbents Appoints Jiny Kim, MBA to its Board of Directors April 5, 2024 ; March. … Board; Executive Management; Advisors; Our Partners; Intellectual Property; … Date Event Details Presentation Webcast; September 2024: CTC Multicenter … CytoSorbents Corporation is a NASDAQ-traded company (CTSO) with more than … CytoSorb ® is the first specifically approved extracorporeal cytokine adsorber in the … CytoSorbents Corporation and CytoSorbents Medical Inc. 305 College … Technology is the Beneficiary of ~$39.5M in Government Funding. CytoSorbents’ … CytoSorb® is a unique blood purification therapy.The product is currently … diciva ugWebDec 17, 2024 · Dr. Phillip Chan, MD, PhD, Chief Executive Officer of CytoSorbents stated, "I am pleased to have this opportunity to publicly recognize Christian's great contributions to CytoSorbents over the more than 9 years we have been working together. Christian has been instrumental in building the CytoSorb business from the very beginning, … bearing nu 314 ecjWebApr 5, 2024 · CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood … bearing nu204eWebApr 9, 2024 · MONMOUTH JUNCTION, N.J. , April 5, 2024 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in … dick \\u0026 janeWebApr 5, 2024 · MONMOUTH JUNCTION, N.J. , April 5, 2024 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO ), a leader in the treatment of life-threatening conditions in … dick \\u0026 dom bogiesWebNov 14, 2014 · Dr. Phillip Chan, Chief Executive Officer of CytoSorbents, commented "In addition to being a member of our Board of Directors, Alan will serve as the … bearing nu1006WebDr. Robert Bartlett 1150 W. Medical Ctr. Dr. MSRB2 B560 Ann Cytosorbents Corp Business Contracts Justia Justia Forms Business Contracts Cytosorbents Corp Dr. Robert Bartlett 1150 W. Medical Ctr. Dr. MSRB2 B560 Ann Dr. Robert Bartlett 1150 W. Medical Ctr. Dr. MSRB2 B560 Ann Arbor, MI 48109 Consulting Agreement bearing nu 316 ecp